Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Oct. 11, 2011

View Archived Issues

New heart valves challenge Edwards in transapical space

PARIS — Europe is back on the frontlines in the development of transcatheter aortic valve implantation (TAVI). (Medical Device Daily) Read More

Greater surgeon control key to new TAVI valves

Washington roundup: Parallel review pilot: just a new saddle on an old nag?

HIT seen as the hottest investment in healthcare

Financings roundup: Zeltiq seeks to raise $128M through IPO

HIT roundup: St. Jude launches new version of Merlin.net

Coming Wednesday in MDD Perspectives: A really bad idea: FDA conducting CE research

Agreements/contracts: Maquet Cardio to supply intra-aortic balloon pumps

Patent watch: Bovie gets electrosurgical leakage device approval

Med-Tech Notes

People in the News

Product Briefs

MDD's Cardio Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 15, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
Australian researchers discover new compound to treat long COVID
BioWorld
Researchers have developed a new compound that can prevent long COVID symptoms in mice that could lead to a future drug for the debilitating condition in humans....
Hightide’s HTD-1801 meets phase III endpoints in type 2 diabetes
BioWorld
Hightide Therapeutics Inc.’s berberine ursodeoxycholate (HTD-1801) met primary and secondary endpoints in the Symphony 1 and Symphony 2 phase III trials in type 2...